Astec LifeSciences Limited has informed the Exchange regarding Board meeting held on June 24, 2025 for raising funds through Rights Issue of Equity Shares.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.5 pts more than Nifty Microcap 250 and 7.6 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Astec LifeSciences, at its meeting on June 24, 2025, approved a Rights Issue of fully paid-up equity shares with a face value of Rs. 10 each for an amount not exceeding Rs. 250 Crore. The issue will be offered to eligible existing equity shareholders on the basis of a record date that will be notified later. The exact issue price, rights entitlement ratio, record date, timing, and payment terms are yet to be decided by the Board or a duly constituted committee. The rights issue will be carried out under the Companies Act, 2013 and SEBI ICDR Regulations, subject to necessary regulatory and statutory approvals.
This is a potential dilution event for non-participating shareholders, and the stock may see downward price adjustment once the ex-rights date is set. Existing shareholders should watch for the record date announcement and the eventual issue price to decide on participating in the rights entitlement.